A Drug Interaction Study of 31001074 and Paroxetine in Healthy Volunteers
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the concentration of 31001074 in blood samples from
healthy volunteers who have been administered 31001074 and paroxetine.
Phase:
Phase 1
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.